Evidence map›Paper›PMID 27821050›Full record

ArticleBMC genomics2016

Stringent comparative sequence analysis reveals SOX10 as a putative inhibitor of glial cell differentiation.

Chetna Gopinath, William D Law, José F Rodríguez-Molina, Arjun B Prasad, Lingyun Song, Gregory E Crawford, James C Mullikin, John Svaren, Anthony Antonellis

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Combinatorial multiomic analysis from a pedigree of Sox10bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Clinical Significance of SOX10 Expression in Human Pathology.Current issues in molecular biology · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Chetna GopinathCellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
William D LawDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
José F Rodríguez-MolinaCellular and Molecular Pathology Program, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Arjun B PrasadGenome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Lingyun SongCenter for Genomic and Computational Biology, Duke University Medical Center, Durham, NC, 27708, USA.
Gregory E CrawfordCenter for Genomic and Computational Biology, Duke University Medical Center, Durham, NC, 27708, USA.
James C MullikinGenome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
John SvarenWaisman Center, University of Wisconsin-Madison, Madison, WI, 53706, USA.
Anthony AntonellisCellular and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI, 48109, USA. antonell@umich.edu.
University of Michigan–Ann Arbor · USDuke University Hospital · USUniversity of Wisconsin–Madison · USNational Human Genome Research Institute · USNational Institutes of Health · US

Funding

Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6M
PREDOCTORAL TRAINING IN GENETICST32GM007544 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORAN, JOHN V. · 1985 to 2022
$11.3M
Regulation of PMP22 Expression in Peripheral NerveR01NS083841 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SVAREN, JOHN P · 2014 to 2018
$1.6M
Dissection of genetic pathways critical for myelinating Schwann cell developmentR01NS073748 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANTONELLIS, ANTHONY · 2011 to 2015
$1.5M
NIGMS NIH HHS T32 GM007544NINDS NIH HHS R01 NS073748NINDS NIH HHS R01 NS083841
6 · The paper itself

Abstract

backgroundThe transcription factor SOX10 is essential for all stages of Schwann cell development including myelination. SOX10 cooperates with other transcription factors to activate the expression of key myelin genes in Schwann cells and is therefore a context-dependent, pro-myelination transcription factor. As such, the identification of genes regulated by SOX10 will provide insight into Schwann cell biology and related diseases. While genome-wide studies have successfully revealed SOX10 target genes, these efforts mainly focused on myelinating stages of Schwann cell development. We propose that less-biased approaches will reveal novel functions of SOX10 outside of myelination.

resultsWe developed a stringent, computational-based screen for genome-wide identification of SOX10 response elements. Experimental validation of a pilot set of predicted binding sites in multiple systems revealed that SOX10 directly regulates a previously unreported alternative promoter at SOX6, which encodes a transcription factor that inhibits glial cell differentiation. We further explored the utility of our computational approach by combining it with DNase-seq analysis in cultured Schwann cells and previously published SOX10 ChIP-seq data from rat sciatic nerve. Remarkably, this analysis enriched for genomic segments that map to loci involved in the negative regulation of gliogenesis including SOX5, SOX6, NOTCH1, HMGA2, HES1, MYCN, ID4, and ID2. Functional studies in Schwann cells revealed that: (1) all eight loci are expressed prior to myelination and down-regulated subsequent to myelination; (2) seven of the eight loci harbor validated SOX10 binding sites; and (3) seven of the eight loci are down-regulated upon repressing SOX10 function.

conclusionsOur computational strategy revealed a putative novel function for SOX10 in Schwann cells, which suggests a model where SOX10 activates the expression of genes that inhibit myelination during non-myelinating stages of Schwann cell development. Importantly, the computational and functional datasets we present here will be valuable for the study of transcriptional regulation, SOX protein function, and glial cell biology.

Indexed as

Cell DifferentiationBase SequenceConsensus SequenceConserved SequenceExonsGenomicsHigh-Throughput Nucleotide SequencingNeurogliaPromoter Regions, GeneticRegulatory Elements, TranscriptionalResponse ElementsSchwann CellsSOXE Transcription FactorsSOXE Transcription FactorsComparative sequence analysisMyelinationSchwann cellsSOX10Transcriptional regulationUltra-conserved sequences

Identifiers

PMID27821050
PMCPMC5100263
OpenAlexW2550189868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.